Creative One Wealth, LLC Biogen Inc. Transaction History

Creative One Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $221,924 - $252,874	865 New	865 $240,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $601,139 - $962,541	-2,321 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $34,984 - $40,986	144 Added 6.61%	2,321 $649,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $514,338 - $774,206	2,177 New	2,177 $533,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.